Omega Diagnostics issues solid H1 trading update

Tuesday, Oct 19 2010 by
2

Omega, the medical diagnostics company, announced that trading was in line with management expectations for the half year to 30 September 2010. Turnover for the period is expected to be £3.3 million (2009: £2.87 million) - 15% ahead of H1 last year. Sales of Genarrayt systems and Food Detective kits are continuing to gain market traction.

Sales of Genarrayt kit and instrument packages increased by approximately 71% to £761k (2009: £443k).vs. H1 2009 and 22 systems were installed during the period - bringing the worldwide total to 80 systems since launch. Genarrayt reagent sales were £632k (2009: £376k). Sales volumes of the macroarray-based Food Detective kits rose to 19,225 (2009: 14,957) and the product is now available in 40 countries worldwide.

Unlock this article instantly by logging into your account

Don’t have an account? Register for free and we’ll get out your way

Disclaimer:  

This note was prepared by LCF Research Limited using information provided by the subject company’s management or publically available news sources. No representations are made nor warranties given (express or implied) in relation to accuracy and completeness. This document is not an invitation to invest in the subject company and does not purport to contain all the necessary information that a prospective investor might require. LCF Research Limited recommends prospective investors to conduct their own thorough independent analysis of the subject company and the information contained in this note or referred to above.


Do you like this Post?
Yes
No
2 thumbs up
0 thumbs down
Share this post with friends



Omega Diagnostics Group PLC is a medical diagnostics company. The Company's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme immunoassay for the semi-quantitative determination of Specific immunoglobulin E (IgE) in serum or plasma. For anemia, it offers ATHOZYME Ferritin, which is an enzyme-immunoassay (ELISA) test for the detection and quantification of Ferritin in human serum. It offers a range of products for Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), Connective Tissue Disease, Gastrointestinal, and Vasculitis and Renal Disease. Its Fertility Hormones products include PATHOZYME-LH (Luteinizing Hormone), PATHOZYME-Prolactin and PATHOZYME-Oestradiol. more »

LSE Price
9.55p
Change
12.4%
Mkt Cap (£m)
11.3
P/E (fwd)
n/a
Yield (fwd)
n/a



  Is LON:ODX fundamentally strong or weak? Find out More »


Please subscribe to submit a comment






Stock Picking Tutorial Centre


Related Content
ODX AND FUM 1
ODX AND FUM 1
LON:ODX 22nd Jul '18



Empresaria EMR H1 results video
Empresaria (EMR) H1 results video
LON:EMR 22nd Aug '18

How should investors forecast earnings growth
How should investors forecast earnings growth?
Growth Investing 14th Feb '12


Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis